375 related articles for article (PubMed ID: 33880507)
21. Nodal-paranodal antibodies in HIV-immune mediated radiculo-neuropathies: Clinical phenotypes and relevance.
Moodley K; Patel VB; Moodley AA; Bill PLA; Kajee A; Mgbachi V; Fehmi J; Rinaldi S
J Peripher Nerv Syst; 2023 Dec; 28(4):578-585. PubMed ID: 37676746
[TBL] [Abstract][Full Text] [Related]
22. Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model.
Doppler K; Schuster Y; Appeltshauser L; Biko L; Villmann C; Weishaupt A; Werner C; Sommer C
J Neuroinflammation; 2019 Apr; 16(1):73. PubMed ID: 30953561
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.
Querol L; Siles AM; Alba-Rovira R; Jáuregui A; Devaux J; Faivre-Sarrailh C; Araque J; Rojas-Garcia R; Diaz-Manera J; Cortés-Vicente E; Nogales-Gadea G; Navas-Madroñal M; Gallardo E; Illa I
Sci Rep; 2017 Oct; 7(1):14411. PubMed ID: 29089585
[TBL] [Abstract][Full Text] [Related]
24. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
25. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
Tang L; Huang Q; Qin Z; Tang X
J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
[TBL] [Abstract][Full Text] [Related]
26. ARTHUR ASBURY LECTURE: Chronic inflammatory demyelinating polyradiculoneuropathy: clinical aspects and new animal models of auto-immunity to nodal components.
Illa I
J Peripher Nerv Syst; 2017 Dec; 22(4):418-424. PubMed ID: 29065233
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance.
Vural A; Doppler K; Meinl E
Front Immunol; 2018; 9():1029. PubMed ID: 29867996
[TBL] [Abstract][Full Text] [Related]
29. Successful autologous hematopoietic stem cell transplantation in a refractory anti-Caspr1 antibody nodopathy.
Afanasiev V; Tsouni P; Kuntzer T; Cairoli A; Delmont E; Vallat JM; Devaux J; Théaudin M
J Peripher Nerv Syst; 2024 Mar; 29(1):116-119. PubMed ID: 38123899
[TBL] [Abstract][Full Text] [Related]
30. Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies.
Doppler K; Stengel H; Appeltshauser L; Grosskreutz J; Man Ng JK; Meinl E; Sommer C
J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1145-1151. PubMed ID: 29945879
[TBL] [Abstract][Full Text] [Related]
31. Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.
Bresciani L; Salvalaggio A; Vegezzi E; Visentin A; Fortuna A; Anglani M; Cacciavillani M; Masciocchi S; Scaranzin S; Carecchio M; Martinuzzi A; Gastaldi M; Briani C
J Peripher Nerv Syst; 2023 Sep; 28(3):522-527. PubMed ID: 37246762
[TBL] [Abstract][Full Text] [Related]
32. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
33. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia.
Miura Y; Devaux JJ; Fukami Y; Manso C; Belghazi M; Wong AH; Yuki N;
Brain; 2015 Jun; 138(Pt 6):1484-91. PubMed ID: 25808373
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against nodo-paranodal proteins are not present in genetic neuropathies.
Martín-Aguilar L; Pascual-Goñi E; Lleixà C; Frasquet M; Argente H; Cano-Abascal A; Diaz-Manera J; Cortés-Vicente E; Pelayo-Negro AL; Sevilla T; Rojas-García R; Querol L
Neurology; 2020 Jul; 95(4):e427-e433. PubMed ID: 32102977
[TBL] [Abstract][Full Text] [Related]
35. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.
Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y
J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967
[TBL] [Abstract][Full Text] [Related]
36. Paranodal and other autoantibodies in chronic inflammatory neuropathies.
Querol L; Illa I
Curr Opin Neurol; 2015 Oct; 28(5):474-9. PubMed ID: 26263474
[TBL] [Abstract][Full Text] [Related]
37. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Querol L; Rojas-García R; Diaz-Manera J; Barcena J; Pardo J; Ortega-Moreno A; Sedano MJ; Seró-Ballesteros L; Carvajal A; Ortiz N; Gallardo E; Illa I
Neurol Neuroimmunol Neuroinflamm; 2015 Oct; 2(5):e149. PubMed ID: 26401517
[TBL] [Abstract][Full Text] [Related]
38. A Systematic Review and Meta-Analysis of Autoantibodies for Diagnosis and Prognosis in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Guo X; Tang L; Huang Q; Tang X
Front Neurosci; 2021; 15():637336. PubMed ID: 34108854
[No Abstract] [Full Text] [Related]
39. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins.
Yang MG; Xu L; Ji S; Gao H; Zhang Q; Bu B
Neuropsychiatr Dis Treat; 2022; 18():1207-1217. PubMed ID: 35734550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]